文献速递瓣膜外科

衰弱对二尖瓣置换术后结局及30天再入院的影响

Effects of Frailty on Outcomes and 30-day Readmissions After Surgical Mitral Valve Replacement.
PubMed 文献 · Ann Thorac Surg · 2020-01-01

基于美国全国再入院数据库2010至2014年50410例孤立二尖瓣置换术成人患者,采用Johns Hopkins衰弱定义指标评估衰弱。7.9%患者符合衰弱标准,衰弱独立增加术后并发症、院内死亡及30天再入院风险,住院费用近乎翻倍。

要点

  • 衰弱患者术后并发症77% vs 47%,院内死亡12% vs 4%。
  • 衰弱独立增加复合并发症风险(AOR 3.28,95%CI 2.61-4.12)。
  • 衰弱独立增加30天再入院风险(AOR 1.47,95%CI 1.20-1.78)。

核心结论

  • 衰弱是二尖瓣置换术后并发症、死亡及费用增加的独立预测因素。
  • 随着经皮二尖瓣介入的普及,需加强对二尖瓣干预患者的衰弱评估。

研究设计与样本

  • 回顾性队列研究,数据来自美国全国再入院数据库2010至2014年。
  • 纳入50410例接受孤立二尖瓣置换术的成人患者。
  • 衰弱采用Johns Hopkins Adjusted Clinical Groups衰弱定义诊断指标判定。
  • 采用多因素logistic回归分析再入院、术后并发症及死亡的危险因素。

主要发现

  • 50410例患者中7.9%符合衰弱标准。
  • 衰弱患者更可能年龄较大、非私人保险、急诊入院及在教学医院接受治疗(均P < .001)。
  • 衰弱患者术后并发症发生率为77% vs 47%(P < .001)。
  • 衰弱患者出院至护理机构的比例为50% vs 21%(P < .001),院内死亡率为12% vs 4%(P < .001)。
  • 衰弱患者指数住院费用近乎翻倍,存活出院者30天再入院率为28% vs 20%(P < .001)。

关键数值与推荐

  • 衰弱独立增加指数住院复合并发症风险(AOR 3.28;95%CI 2.61-4.12)。
  • 衰弱独立增加院内死亡风险(AOR 2.35;95%CI 1.90-2.92)。
  • 衰弱独立增加30天再入院风险(AOR 1.47;95%CI 1.20-1.78)。

临床怎么用

  • 对拟行二尖瓣置换术的患者应进行衰弱评估以识别高危人群。
  • 衰弱患者术后并发症、死亡及再入院风险高,需加强围术期管理与出院规划。
  • 在考虑经皮二尖瓣介入时,衰弱评估有助于医患共同决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Frailty is increasingly recognized as an important prognostic marker in surgical populations. The effects of frailty on outcomes after mitral valve replacement (MVR) is less clear given the inherent complexity of this patient population. We evaluated the influences of frailty on outcomes and readmission rates after MVR. METHODS: Adult patients undergoing isolated MVR were queried from the National Readmissions Database from 2010 to 2014. Frailty was defined using the Johns Hopkins Adjusted Clinical Groups frailty-defining diagnoses indicator, a validated instrument developed for use in health administrative data. Multivariable logistic regression was used to determine hospital- and patient-level risk factors for readmission, postoperative complications, and death. RESULTS: Among 50,410 patients who underwent MVR, 7.9% met frailty criteria. Frail patients were more likely to be older, have nonprivate insurance, an index admission from the emergency department, and teaching hospital care (all P < .001). Frail patients had significantly more postoperative complications (77% vs 47%, P < .001), more discharges to a facility (50% vs 21%, P < .001), and higher in-hospital mortality (12% vs 4%, P < .001). Index hospitalization costs were almost doubled in frail patients, and of those who survived to discharge, 30-day readmissions were more frequent (28% vs 20%, P < .001). Frailty independently increased the risk of index hospitalization composite complications (adjusted odds ratio [AOR], 3.28; 95% confidence interval [CI], 2.61-4.12), in-hospital mortality (AOR, 2.35; 95% CI, 1.90-2.92), and 30-day readmission (AOR, 1.47; 95% CI, 1.20-1.78). CONCLUSIONS: Frailty is an independent predictor of morbidity, death, and increased costs after MVR. Frailty metrics should be increasingly understood among patients requiring mitral valve intervention as percutaneous approaches for intervention become increasingly used.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Iyengar A, Goel N, Kelly JJ, et al. Effects of Frailty on Outcomes and 30-day Readmissions After Surgical Mitral Valve Replacement. Ann Thorac Surg. 2020. PMID: 32200907. doi:10.1016/j.athoracsur.2019.10.087

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。